Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watabe, M.
Right arrow Articles by Osada, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watabe, M.
Right arrow Articles by Osada, H.
[Cancer Research 60, 5214-5222, September 15, 2000]
© 2000 American Association for Cancer Research


Experimental Therapeutics

MT-21 Is a Synthetic Apoptosis Inducer That Directly Induces Cytochrome c Release from Mitochondria1

Masahiko Watabe, Kiyotaka Machida and Hiroyuki Osada2

Antibiotics Laboratory, Riken Institute, Hirosawa 2-1, Wako-shi, Saitama 351-0198, Japan

We reported previously that a synthetic compound, MT-21, induced apoptosis by activating c-Jun-NH2-terminal kinase via the Krs/MST protein, which is activated by caspase-3 cleavage dependent on reactive oxygen species production. Here we examine the activation mechanism of caspase-3, an important cysteine aspartic protease, during MT-21-induced apoptosis. We found that MT-21 activated caspase-3 via caspase-9, but not via caspase-8. In addition, MT-21 induced the release of cytochrome c from the mitochondria that is necessary to activate caspase-9, and this release occurred before a change in membrane potential. This initiation process of MT-21-induced apoptosis was suppressed by overexpression of Bcl-2, which is known to prevent cells from undergoing apoptosis in response to a variety of stimuli. Moreover, when we treated mitochondria isolated from the cells with MT-21, the direct release of cytochrome c from the mitochondria was observed, whereas this effect was not observed in the mitochondria isolated from cells that overexpressed Bcl-2. Other apoptosis-inducing agents known to induce apoptosis via cytochrome c release from the mitochondria failed to release cytochrome c directly from isolated mitochondria. These findings indicate that MT-21 is a possible candidate antitumor agent that is able to induce apoptosis via the direct release of cytochrome c from the mitochondria.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Watabe and T. Nakaki
Mitochondrial Complex I Inhibitor Rotenone Inhibits and Redistributes Vesicular Monoamine Transporter 2 via Nitration in Human Dopaminergic SH-SY5Y Cells
Mol. Pharmacol., October 1, 2008; 74(4): 933 - 940.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Watabe, K. Aoyama, and T. Nakaki
A Dominant Role of GTRAP3-18 in Neuronal Glutathione Synthesis
J. Neurosci., September 17, 2008; 28(38): 9404 - 9413.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Watabe and T. Nakaki
Mitochondrial Complex I Inhibitor Rotenone-Elicited Dopamine Redistribution from Vesicles to Cytosol in Human Dopaminergic SH-SY5Y Cells
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 499 - 507.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Watabe, K. Aoyama, and T. Nakaki
Regulation of Glutathione Synthesis via Interaction between Glutamate Transport-Associated Protein 3-18 (GTRAP3-18) and Excitatory Amino Acid Carrier-1 (EAAC1) at Plasma Membrane
Mol. Pharmacol., November 1, 2007; 72(5): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-C. Lee, C.-H. Lee, C.-L. Su, C.-W. Huang, H.-S. Liu, C.-N. Lin, and S.-J. Won
Justicidin A decreases the level of cytosolic Ku70 leading to apoptosis in human colorectal cancer cells
Carcinogenesis, October 1, 2005; 26(10): 1716 - 1730.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Watabe and T. Nakaki
Rotenone Induces Apoptosis via Activation of Bad in Human Dopaminergic SH-SY5Y Cells
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 948 - 953.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Kondoh, I. Suzuki, M. Sato, F. Nagashima, S. Simizu, M. Harada, M. Fujii, H. Osada, Y. Asakawa, and Y. Watanabe
Kaurene Diterpene Induces Apoptosis in Human Leukemia Cells Partly through a Caspase-8-Dependent Pathway
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Watabe, K. Hishikawa, A. Takayanagi, N. Shimizu, and T. Nakaki
Caffeic Acid Phenethyl Ester Induces Apoptosis by Inhibition of NF{kappa}B and Activation of Fas in Human Breast Cancer MCF-7 Cells
J. Biol. Chem., February 13, 2004; 279(7): 6017 - 6026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Machida, Y. Hayashi, and H. Osada
A Novel Adenine Nucleotide Translocase Inhibitor, MT-21, Induces Cytochrome c Release by a Mitochondrial Permeability Transition-independent Mechanism
J. Biol. Chem., August 16, 2002; 277(34): 31243 - 31248.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. M. Smith, A. Kazi, L. Smith, T. E. Long, B. Heldreth, E. Turos, and Q. P. Dou
A Novel beta -Lactam Antibiotic Activates Tumor Cell Apoptotic Program by Inducing DNA Damage
Mol. Pharmacol., June 1, 2002; 61(6): 1348 - 1358.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Chen, D. L. Kramer, P. Diegelman, S. Vujcic, and C. W. Porter
Apoptotic Signaling in Polyamine Analogue-treated SK-MEL-28 Human Melanoma Cells
Cancer Res., September 1, 2001; 61(17): 6437 - 6444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.